Ummu Afeera Zainulabid et al. 2024. The Persistence of Antibodies in ESRD Patients 12 Months after the BNT162b2 Vaccine Booster Dose. Asian Journal of Medicine & Health Sciences. 7, 1 (Jun. 2024), 87–93.